Breast cancer risk is a central concern in shared decision-making when considering menopausal hormone treatment (MHT). Women spend approximately 40% of their lives in menopause, and climacteric ...

This randomized controlled trial found that, in patients with hormone-receptor-positive, HER2-positive metastatic breast ...

A bitter taste has always been considered a warning signal, devoted to protecting us from ingesting potentially harmful ...

Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026.

Estrogen receptor β (ERβ) plays an important role in both the mouse and human prostate. The endogenous ligand for ERβ is the dihydrotestosterone metabolite, 5β-androstane-3β, 17β-diol (3β-Adiol). T ...

To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.

Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Selective estrogen receptor modulators (SERMs) are nonsteroidal compounds that exert context-dependent agonist or antagonist effects on estrogen receptors through ligand-induced conformational changes ...

Stress, the body's natural response to different types of challenges and daily problems, is an inherently harmless state experienced by most people worldwide. While short-term stress is a common ...

Researchers discover that estrogen can turn on pain signals associated with conditions like irritable bowel syndrome. Women are dramatically more likely than men to suffer from irritable bowel ...